Usually, 30% to 40% of SLE patients have aPL antibodies, however, only 10% progress to APS, and 1% of those with APS lead to catastrophic APS.13 The frequency of DAH among patients with APS has been reported as <1–21%.9 In the literature, almost 13 more cases were reported to have thrombocytopenia,2,9–11,13–16 however, only a few have additional aPL antibodies and aPL syndrome.2,9 Anti-nuclear antibody and anti-DNA tests were positive and complement levels were low in most of the cases. This evidence concerns the gene FASLG and Thrombocytopenia.